0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lesinurad - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-12S12995
Home | Market Reports | Health
Global Lesinurad Market Research Report 2023
BUY CHAPTERS

Lesinurad - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12S12995
Report
March 2024
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lesinurad - Market

Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.
The global market for Lesinurad was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global market may be influenced by the prevalence of conditions, as well as healthcare infrastructure and access to healthcare in different regions.The patent status of a drug can significantly influence market trends. If the patent has expired or is close to expiring, it can lead to the entry of generic versions, which can affect market dynamics, pricing, and competition.Market trends may be influenced by the approval of new indications or the expansion of the drug's approved use. If new indications receives approval for additional medical conditions, it could potentially lead to increased sales and market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lesinurad, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lesinurad by region & country, by Type, and by Application.
The Lesinurad market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lesinurad.
Market Segmentation

Scope of Lesinurad - Market Report

Report Metric Details
Report Name Lesinurad - Market
Segment by Type:
  • Purity ≥ 98 %
  • Purity ≥ 99 %
Segment by Application
  • Research Institute
  • Pharmaceutical
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ausun Pharmaceutical, Cayman Chemical, Clearsynth, Target Mol, UQUIFA, MSN Labs, CHEMO, Nifty Labs, Manus Aktteva Biopharma LLP, Vcare Pharmatech, Meso Chem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Lesinurad manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Lesinurad in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Lesinurad in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Lesinurad - Market report?

Ans: The main players in the Lesinurad - Market are Ausun Pharmaceutical, Cayman Chemical, Clearsynth, Target Mol, UQUIFA, MSN Labs, CHEMO, Nifty Labs, Manus Aktteva Biopharma LLP, Vcare Pharmatech, Meso Chem

What are the Application segmentation covered in the Lesinurad - Market report?

Ans: The Applications covered in the Lesinurad - Market report are Research Institute, Pharmaceutical, Others

What are the Type segmentation covered in the Lesinurad - Market report?

Ans: The Types covered in the Lesinurad - Market report are Purity ≥ 98 %, Purity ≥ 99 %

1 Market Overview
1.1 Lesinurad Product Introduction
1.2 Global Lesinurad Market Size Forecast
1.2.1 Global Lesinurad Sales Value (2019-2030)
1.2.2 Global Lesinurad Sales Volume (2019-2030)
1.2.3 Global Lesinurad Sales Price (2019-2030)
1.3 Lesinurad Market Trends & Drivers
1.3.1 Lesinurad Industry Trends
1.3.2 Lesinurad Market Drivers & Opportunity
1.3.3 Lesinurad Market Challenges
1.3.4 Lesinurad Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lesinurad Players Revenue Ranking (2023)
2.2 Global Lesinurad Revenue by Company (2019-2024)
2.3 Global Lesinurad Players Sales Volume Ranking (2023)
2.4 Global Lesinurad Sales Volume by Company Players (2019-2024)
2.5 Global Lesinurad Average Price by Company (2019-2024)
2.6 Key Manufacturers Lesinurad Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lesinurad Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lesinurad
2.9 Lesinurad Market Competitive Analysis
2.9.1 Lesinurad Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lesinurad Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lesinurad as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity ≥ 98 %
3.1.2 Purity ≥ 99 %
3.2 Global Lesinurad Sales Value by Type
3.2.1 Global Lesinurad Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lesinurad Sales Value, by Type (2019-2030)
3.2.3 Global Lesinurad Sales Value, by Type (%) (2019-2030)
3.3 Global Lesinurad Sales Volume by Type
3.3.1 Global Lesinurad Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lesinurad Sales Volume, by Type (2019-2030)
3.3.3 Global Lesinurad Sales Volume, by Type (%) (2019-2030)
3.4 Global Lesinurad Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institute
4.1.2 Pharmaceutical
4.1.3 Others
4.2 Global Lesinurad Sales Value by Application
4.2.1 Global Lesinurad Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lesinurad Sales Value, by Application (2019-2030)
4.2.3 Global Lesinurad Sales Value, by Application (%) (2019-2030)
4.3 Global Lesinurad Sales Volume by Application
4.3.1 Global Lesinurad Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lesinurad Sales Volume, by Application (2019-2030)
4.3.3 Global Lesinurad Sales Volume, by Application (%) (2019-2030)
4.4 Global Lesinurad Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lesinurad Sales Value by Region
5.1.1 Global Lesinurad Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lesinurad Sales Value by Region (2019-2024)
5.1.3 Global Lesinurad Sales Value by Region (2025-2030)
5.1.4 Global Lesinurad Sales Value by Region (%), (2019-2030)
5.2 Global Lesinurad Sales Volume by Region
5.2.1 Global Lesinurad Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lesinurad Sales Volume by Region (2019-2024)
5.2.3 Global Lesinurad Sales Volume by Region (2025-2030)
5.2.4 Global Lesinurad Sales Volume by Region (%), (2019-2030)
5.3 Global Lesinurad Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lesinurad Sales Value, 2019-2030
5.4.2 North America Lesinurad Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lesinurad Sales Value, 2019-2030
5.5.2 Europe Lesinurad Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lesinurad Sales Value, 2019-2030
5.6.2 Asia Pacific Lesinurad Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lesinurad Sales Value, 2019-2030
5.7.2 South America Lesinurad Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lesinurad Sales Value, 2019-2030
5.8.2 Middle East & Africa Lesinurad Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lesinurad Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lesinurad Sales Value
6.2.1 Key Countries/Regions Lesinurad Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lesinurad Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lesinurad Sales Value, 2019-2030
6.3.2 United States Lesinurad Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lesinurad Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lesinurad Sales Value, 2019-2030
6.4.2 Europe Lesinurad Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lesinurad Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lesinurad Sales Value, 2019-2030
6.5.2 China Lesinurad Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lesinurad Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lesinurad Sales Value, 2019-2030
6.6.2 Japan Lesinurad Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lesinurad Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lesinurad Sales Value, 2019-2030
6.7.2 South Korea Lesinurad Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lesinurad Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lesinurad Sales Value, 2019-2030
6.8.2 Southeast Asia Lesinurad Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lesinurad Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lesinurad Sales Value, 2019-2030
6.9.2 India Lesinurad Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lesinurad Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ausun Pharmaceutical
7.1.1 Ausun Pharmaceutical Company Information
7.1.2 Ausun Pharmaceutical Introduction and Business Overview
7.1.3 Ausun Pharmaceutical Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ausun Pharmaceutical Lesinurad Product Offerings
7.1.5 Ausun Pharmaceutical Recent Development
7.2 Cayman Chemical
7.2.1 Cayman Chemical Company Information
7.2.2 Cayman Chemical Introduction and Business Overview
7.2.3 Cayman Chemical Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Cayman Chemical Lesinurad Product Offerings
7.2.5 Cayman Chemical Recent Development
7.3 Clearsynth
7.3.1 Clearsynth Company Information
7.3.2 Clearsynth Introduction and Business Overview
7.3.3 Clearsynth Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Clearsynth Lesinurad Product Offerings
7.3.5 Clearsynth Recent Development
7.4 Target Mol
7.4.1 Target Mol Company Information
7.4.2 Target Mol Introduction and Business Overview
7.4.3 Target Mol Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Target Mol Lesinurad Product Offerings
7.4.5 Target Mol Recent Development
7.5 UQUIFA
7.5.1 UQUIFA Company Information
7.5.2 UQUIFA Introduction and Business Overview
7.5.3 UQUIFA Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.5.4 UQUIFA Lesinurad Product Offerings
7.5.5 UQUIFA Recent Development
7.6 MSN Labs
7.6.1 MSN Labs Company Information
7.6.2 MSN Labs Introduction and Business Overview
7.6.3 MSN Labs Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MSN Labs Lesinurad Product Offerings
7.6.5 MSN Labs Recent Development
7.7 CHEMO
7.7.1 CHEMO Company Information
7.7.2 CHEMO Introduction and Business Overview
7.7.3 CHEMO Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CHEMO Lesinurad Product Offerings
7.7.5 CHEMO Recent Development
7.8 Nifty Labs
7.8.1 Nifty Labs Company Information
7.8.2 Nifty Labs Introduction and Business Overview
7.8.3 Nifty Labs Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nifty Labs Lesinurad Product Offerings
7.8.5 Nifty Labs Recent Development
7.9 Manus Aktteva Biopharma LLP
7.9.1 Manus Aktteva Biopharma LLP Company Information
7.9.2 Manus Aktteva Biopharma LLP Introduction and Business Overview
7.9.3 Manus Aktteva Biopharma LLP Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Manus Aktteva Biopharma LLP Lesinurad Product Offerings
7.9.5 Manus Aktteva Biopharma LLP Recent Development
7.10 Vcare Pharmatech
7.10.1 Vcare Pharmatech Company Information
7.10.2 Vcare Pharmatech Introduction and Business Overview
7.10.3 Vcare Pharmatech Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Vcare Pharmatech Lesinurad Product Offerings
7.10.5 Vcare Pharmatech Recent Development
7.11 Meso Chem
7.11.1 Meso Chem Company Information
7.11.2 Meso Chem Introduction and Business Overview
7.11.3 Meso Chem Lesinurad Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Meso Chem Lesinurad Product Offerings
7.11.5 Meso Chem Recent Development
8 Industry Chain Analysis
8.1 Lesinurad Industrial Chain
8.2 Lesinurad Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lesinurad Sales Model
8.5.2 Sales Channel
8.5.3 Lesinurad Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Lesinurad Market Trends
    Table 2. Lesinurad Market Drivers & Opportunity
    Table 3. Lesinurad Market Challenges
    Table 4. Lesinurad Market Restraints
    Table 5. Global Lesinurad Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Lesinurad Revenue Market Share by Company (2019-2024)
    Table 7. Global Lesinurad Sales Volume by Company (2019-2024) & (Tons)
    Table 8. Global Lesinurad Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Lesinurad Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Lesinurad Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Lesinurad Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Lesinurad
    Table 13. Global Lesinurad Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lesinurad as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Lesinurad Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Lesinurad Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Lesinurad Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Lesinurad Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Lesinurad Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Lesinurad Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
    Table 22. Global Lesinurad Sales Volume by Type (2019-2024) & (Tons)
    Table 23. Global Lesinurad Sales Volume by Type (2025-2030) & (Tons)
    Table 24. Global Lesinurad Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Lesinurad Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Lesinurad Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Lesinurad Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Lesinurad Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Lesinurad Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Lesinurad Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Lesinurad Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Lesinurad Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Lesinurad Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
    Table 34. Global Lesinurad Sales Volume by Application (2019-2024) & (Tons)
    Table 35. Global Lesinurad Sales Volume by Application (2025-2030) & (Tons)
    Table 36. Global Lesinurad Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Lesinurad Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Lesinurad Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Lesinurad Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Lesinurad Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Lesinurad Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Lesinurad Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Lesinurad Sales Value by Region (2019-2024) & (%)
    Table 44. Global Lesinurad Sales Value by Region (2025-2030) & (%)
    Table 45. Global Lesinurad Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
    Table 46. Global Lesinurad Sales Volume by Region (2019-2024) & (Tons)
    Table 47. Global Lesinurad Sales Volume by Region (2025-2030) & (Tons)
    Table 48. Global Lesinurad Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Lesinurad Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Lesinurad Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Lesinurad Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Lesinurad Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Lesinurad Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Lesinurad Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Lesinurad Sales Volume, (2019-2024) & (Tons)
    Table 56. Key Countries/Regions Lesinurad Sales Volume, (2025-2030) & (Tons)
    Table 57. Ausun Pharmaceutical Company Information
    Table 58. Ausun Pharmaceutical Introduction and Business Overview
    Table 59. Ausun Pharmaceutical Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. Ausun Pharmaceutical Lesinurad Product Offerings
    Table 61. Ausun Pharmaceutical Recent Development
    Table 62. Cayman Chemical Company Information
    Table 63. Cayman Chemical Introduction and Business Overview
    Table 64. Cayman Chemical Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. Cayman Chemical Lesinurad Product Offerings
    Table 66. Cayman Chemical Recent Development
    Table 67. Clearsynth Company Information
    Table 68. Clearsynth Introduction and Business Overview
    Table 69. Clearsynth Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Clearsynth Lesinurad Product Offerings
    Table 71. Clearsynth Recent Development
    Table 72. Target Mol Company Information
    Table 73. Target Mol Introduction and Business Overview
    Table 74. Target Mol Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. Target Mol Lesinurad Product Offerings
    Table 76. Target Mol Recent Development
    Table 77. UQUIFA Company Information
    Table 78. UQUIFA Introduction and Business Overview
    Table 79. UQUIFA Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. UQUIFA Lesinurad Product Offerings
    Table 81. UQUIFA Recent Development
    Table 82. MSN Labs Company Information
    Table 83. MSN Labs Introduction and Business Overview
    Table 84. MSN Labs Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. MSN Labs Lesinurad Product Offerings
    Table 86. MSN Labs Recent Development
    Table 87. CHEMO Company Information
    Table 88. CHEMO Introduction and Business Overview
    Table 89. CHEMO Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 90. CHEMO Lesinurad Product Offerings
    Table 91. CHEMO Recent Development
    Table 92. Nifty Labs Company Information
    Table 93. Nifty Labs Introduction and Business Overview
    Table 94. Nifty Labs Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 95. Nifty Labs Lesinurad Product Offerings
    Table 96. Nifty Labs Recent Development
    Table 97. Manus Aktteva Biopharma LLP Company Information
    Table 98. Manus Aktteva Biopharma LLP Introduction and Business Overview
    Table 99. Manus Aktteva Biopharma LLP Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 100. Manus Aktteva Biopharma LLP Lesinurad Product Offerings
    Table 101. Manus Aktteva Biopharma LLP Recent Development
    Table 102. Vcare Pharmatech Company Information
    Table 103. Vcare Pharmatech Introduction and Business Overview
    Table 104. Vcare Pharmatech Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 105. Vcare Pharmatech Lesinurad Product Offerings
    Table 106. Vcare Pharmatech Recent Development
    Table 107. Meso Chem Company Information
    Table 108. Meso Chem Introduction and Business Overview
    Table 109. Meso Chem Lesinurad Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 110. Meso Chem Lesinurad Product Offerings
    Table 111. Meso Chem Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Lesinurad Downstream Customers
    Table 115. Lesinurad Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Lesinurad Product Picture
    Figure 2. Global Lesinurad Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Lesinurad Sales Volume (2019-2030) & (Tons)
    Figure 5. Global Lesinurad Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Lesinurad Report Years Considered
    Figure 7. Global Lesinurad Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Lesinurad Players Sales Volume Ranking (2023) & (Tons)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lesinurad Revenue in 2023
    Figure 10. Lesinurad Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Purity ≥ 98 % Picture
    Figure 12. Purity ≥ 99 % Picture
    Figure 13. Global Lesinurad Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Lesinurad Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Lesinurad Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
    Figure 16. Global Lesinurad Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Lesinurad Price by Type (2019-2030) & (US$/Ton)
    Figure 18. Product Picture of Research Institute
    Figure 19. Product Picture of Pharmaceutical
    Figure 20. Product Picture of Others
    Figure 21. Global Lesinurad Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Lesinurad Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Lesinurad Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
    Figure 24. Global Lesinurad Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Lesinurad Price by Application (2019-2030) & (US$/Ton)
    Figure 26. North America Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Lesinurad Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Lesinurad Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Lesinurad Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Lesinurad Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Lesinurad Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Lesinurad Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Lesinurad Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Lesinurad Sales Volume (%), (2019-2030)
    Figure 38. United States Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Lesinurad Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Lesinurad Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Lesinurad Sales Value by Application (%), 2023 VS 2030
    Figure 59. Lesinurad Industrial Chain
    Figure 60. Lesinurad Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Healthcare Information Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12H6156
Fri Sep 12 00:00:00 UTC 2025

Add to Cart